Vandetanib for thyroid cancer

被引：0
|
作者：
Takahashi, Shunji [1 ]
机构：
[1] JFCR, Canc Inst Hosp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-6-1
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
    Deshpande, Hari
    Marler, Vicky
    Sosa, Julie Ann
    ONCOTARGETS AND THERAPY, 2011, 4 : 209 - 215
  • [32] Vandetanib for the Treatment of Medullary Thyroid Carcinoma
    Cooper, Maryann R.
    Yi, Soo Yun
    Alghamdi, Wael
    Shaheen, Daniel J.
    Steinberg, Michael
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (03) : 387 - 394
  • [33] Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
    Fallahi, Poupak
    Ferrari, Silvia Martina
    Elia, Giusy
    Ragusa, Francesca
    Paparo, Sabrina Rosaria
    Ruffilli, Ilaria
    Patrizio, Armando
    Materazzi, Gabriele
    Antonelli, Alessandro
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7893 - 7907
  • [34] Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy
    Brose, Marcia S.
    Capdevila, Jaume
    Elisei, Rossella
    Bastholt, Lars
    Fuehrer-Sakel, Dagmar
    Leboulleux, Sophie
    Sugitani, Iwao
    Taylor, Matthew H.
    Wang, Zhuoying
    Wirth, Lori J.
    Worden, Francis P.
    Bernard, John
    Caferra, Paolo
    Colzani, Raffaella M.
    Liu, Shiguang
    Schlumberger, Martin
    ENDOCRINE-RELATED CANCER, 2024, 31 (08)
  • [35] Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients
    Tiedje, Vera
    Ting, Saskia
    Walter, Robert Fred
    Herold, Thomas
    Worm, Karl
    Badziong, Julia
    Zwanziger, Denise
    Schmid, Kurt Werner
    Fuehrer, Dagmar
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 175 (03) : 173 - 180
  • [36] Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
    Jalalat, Sheila Z.
    Cohen, Philip R.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (06) : E213 - E216
  • [37] Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer
    Brassard, Maryse
    Neraud, Barbara
    Trabado, Severine
    Salenave, Sylvie
    Brailly-Tabard, Sylvie
    Borget, Isabelle
    Baudin, Eric
    Leboulleux, Sophie
    Chanson, Philippe
    Schlumberger, Martin
    Young, Jacques
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (09): : 2741 - 2749
  • [38] Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
    Grande, Enrique
    Kreissl, Michael C.
    Filetti, Sebastiano
    Newbold, Kate
    Reinisch, Walter
    Robert, Caroline
    Schlumberger, Martin
    Tolstrup, Laerke K.
    Zamorano, Jose L.
    Capdevila, Jaume
    ADVANCES IN THERAPY, 2013, 30 (11) : 945 - 966
  • [39] Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
    Enrique Grande
    Michael C. Kreissl
    Sebastiano Filetti
    Kate Newbold
    Walter Reinisch
    Caroline Robert
    Martin Schlumberger
    Lærke K. Tolstrup
    Jose L. Zamorano
    Jaume Capdevila
    Advances in Therapy, 2013, 30 : 945 - 966
  • [40] Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
    Wells, Samuel A., Jr.
    Gosnell, Jessica E.
    Gagel, Robert F.
    Moley, Jeffrey
    Pfister, David
    Sosa, Julie A.
    Skinner, Michael
    Krebs, Annetta
    Vasselli, James
    Schlumberger, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 767 - 772
12345